Milestone Pharmaceuticals Inc. — Form D

Milestone Pharmaceuticals Inc. of MONTREAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-15. The offering totals $9.4M, of which $3.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Ela BorensteinDirectorMontreal, A8
Philippe DouvilleDirectorMontreal, A8
Debra LiebertDirectorMontreal, A8
Yves RosconiDirectorMontreal, A8
Paul TruexDirectorSanta Clara, CA
Scott WeinerDirectorNew York, NY
Nathalie BeauregardExecutive OfficerMontreal, A8
Benjamin CowenExecutive OfficerMontreal, A8
Philippe DouvilleExecutive OfficerMontreal, A8
Martin MaguireExecutive OfficerMontreal, A8
Francis PlatExecutive OfficerMontreal, A8
Paul TruexExecutive OfficerSanta Clara, CA
Douglas WightExecutive OfficerMontreal, A8
Guy G RousseauExecutive OfficerMontreal, A8
Nilesh G KumarDirectorMontreal, A8
Debra G LiebertDirectorMontreal, A8
Paul G TruexDirectorMontreal, A8
Francis G PlatExecutive OfficerMontreal, A8
Joseph G OlivetoDirectorMontreal, A8
Joseph G OlivetoExecutive OfficerMontreal, A8
Douglas G WightExecutive OfficerMontreal, A8
Philippe G DouvilleExecutive OfficerMontreal, A8
Marco G BoorsmaDirectorMontreal, A8
Harish G PimplaskarExecutive OfficerMontreal, A8
Lorenz G MullerExecutive OfficerMontreal, A8

Other filings by this issuer (3)

FiledFormOfferingSold
2018-10-26D$80.0M$80.0M
2017-07-25D$6.9M$6.9M
2011-06-14D$596K$596K

More